Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sangamo Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Sangamo Therapeutics

Sangamo Therapeutics

Public

Sangamo Therapeutics, Inc.: A US-based biotech firm specializing in genomic therapies for genetic diseases.

HQ
Richmond, CA, US
Founded
1995
Overview
Compare
Fundraising
Employees
Website

Founded in the United States, Sangamo Therapeutics, Inc. is a biotechnology company dedicated to pioneering the future of genomic medicine. The company's core mission is to translate groundbreaking science into cures for severe genetic diseases, leveraging its proprietary zinc finger technology. Sangamo focuses on developing genomic therapies that aim to provide lasting solutions rather than merely managing symptoms, addressing unmet medical needs in the field of genetic disorders.

Notable figures associated with Sangamo include its team of leading scientists and researchers who drive its innovative projects. The company has attracted significant investment from various healthcare and biotech investors, bolstering its research and development efforts. Key achievements include advancements in zinc finger technology and the development of potential treatments for conditions such as hemophilia and sickle cell disease. Sangamo's work has had a substantial impact on the biotechnology landscape, pushing the boundaries of genomic medicine and offering hope to patients with previously untreatable genetic diseases.

Sangamo Therapeutics - Similar Companies

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Encoded Therapeutics logo

Encoded Therapeutics

Solid Biosciences logo

Solid Biosciences

solidbio.com

BridgeBio Pharma logo

BridgeBio Pharma

bridgebio.com

Denali Therapeutics logo

Denali Therapeutics

Singular Genomics logo

Singular Genomics

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

Poseida Therapeutics logo

Poseida Therapeutics

poseida.com

Regenxbio logo

Regenxbio

regenxbio.com

Soleno Therapeutics logo

Soleno Therapeutics

soleno.life

bluebird bio logo

bluebird bio

bluebirdbio.com

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Excision BioTherapeutics logo

Excision BioTherapeutics

Generation Bio logo

Generation Bio

generationbio.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

Sangamo Therapeutics - Quick Facts

Who are Sangamo Therapeutics' competitors?

Companies similar to Sangamo Therapeutics include Cogent Biosciences, Encoded Therapeutics, Solid Biosciences and BridgeBio Pharma.

When was Sangamo Therapeutics founded?

Sangamo Therapeutics was founded in 1995.

Where is Sangamo Therapeutics' headquarters located?

Sangamo Therapeutics' headquarters is located in Richmond, CA, US.

When was Sangamo Therapeutics' last funding round?

Sangamo Therapeutics' most recent funding round was for $145.5M (USD) in April 2019.

How much has Sangamo Therapeutics raised to-date?

As of Apr 3, 2019, Sangamo Therapeutics has raised a total of $522.1M (USD).

How many employees does Sangamo Therapeutics have?

Sangamo Therapeutics has 478 employees as of Feb 5, 2024.

Sangamo Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Genomic Therapies
Tags
  • Healthtech
Unique IDs
  • ein: 680359556
  • secCik: 0001001233
  • ticker: SGMO
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 17 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering